These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12069935)

  • 1. GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats.
    Rinaman L; Rothe EE
    Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R99-106. PubMed ID: 12069935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.
    Rinaman L
    Am J Physiol; 1999 Nov; 277(5):R1537-40. PubMed ID: 10564228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.
    Thiele TE; Seeley RJ; D'Alessio D; Eng J; Bernstein IL; Woods SC; van Dijk G
    Brain Res; 1998 Aug; 801(1-2):164-70. PubMed ID: 9729361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
    Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
    J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ; Tang-Christensen M; Jessop DS
    Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hindbrain oxytocin receptors contribute to the effects of circulating oxytocin on food intake in male rats.
    Ho JM; Anekonda VT; Thompson BW; Zhu M; Curry RW; Hwang BH; Morton GJ; Schwartz MW; Baskin DG; Appleyard SM; Blevins JE
    Endocrinology; 2014 Aug; 155(8):2845-57. PubMed ID: 24877632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness.
    Kinzig KP; D'Alessio DA; Seeley RJ
    J Neurosci; 2002 Dec; 22(23):10470-6. PubMed ID: 12451146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.
    Hayes MR; Bradley L; Grill HJ
    Endocrinology; 2009 Jun; 150(6):2654-9. PubMed ID: 19264875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricular injection of fusaric acid attenuates the anorexia by glucagon-like peptide-1 in the neonatal chick.
    Bungo T; Kawakami SI; Ohgushi A; Sashihara K; Saito N; Sugahara K; Hasegawa S; Denbow DM; Furuse M
    Pharmacol Biochem Behav; 2001; 70(2-3):251-5. PubMed ID: 11701195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.
    Dossat AM; Lilly N; Kay K; Williams DL
    J Neurosci; 2011 Oct; 31(41):14453-7. PubMed ID: 21994361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
    Davis HR; Mullins DE; Pines JM; Hoos LM; France CF; Compton DS; Graziano MP; Sybertz EJ; Strader CD; Van Heek M
    Obes Res; 1998 Mar; 6(2):147-56. PubMed ID: 9545022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
    Chelikani PK; Haver AC; Reidelberger RD
    Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Diabetes; 2004 Sep; 53(9):2492-500. PubMed ID: 15331566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
    Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
    J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat.
    Bojanowska E; Stempniak B
    Regul Pept; 2000 Jul; 91(1-3):75-81. PubMed ID: 10967203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons.
    Katsurada K; Maejima Y; Nakata M; Kodaira M; Suyama S; Iwasaki Y; Kario K; Yada T
    Biochem Biophys Res Commun; 2014 Aug; 451(2):276-81. PubMed ID: 25089000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
    Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
    Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
    Seeley RJ; Blake K; Rushing PA; Benoit S; Eng J; Woods SC; D'Alessio D
    J Neurosci; 2000 Feb; 20(4):1616-21. PubMed ID: 10662851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
    Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
    J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.